Solution reagent kit STG series

for researchthrombin

A range of reagents specifically developed for ST Genesia is available: STG-ThromboScreen: Thrombin generation assessment in patients who are likely to suffer from thrombophilia. STG-BleedScreen*: Thrombin generation assessment in patients with bleeding risk, such as haemophiliacs. STG-DrugScreen*: Assessment of the effect of anticoagulants on treated patients, which could be useful for people at risk of drug accumulation (impaired renal function, people over 75, etc.). ST Genesia has been presented at ISTH, SSC, Club IIa, ST Genesia Expert Event, Symposium. The high attendance at Stago stands, numerous requests for demonstrations as well as the large number of attendees at Stago events are all indications of the keen interest of the scientific and medical community in this new system. ST Genesia and STG-ThromboScreen are now CE marked and available to order. Don’t hesitate to get in touch with your Stago representative for more information.